The receptor-selectivity profile traces back to the two non-coded residues (-aminoisobutyric acid at position 1 and D-2-naphthylalanine at position 3) and the D-phenylalanine at position 4
Injection volumes never exceed a quarter of a milliliter
Additionally, disruptions in the blood-brain barrier in those with neurocognitive symptoms have been observed, as well as hypoperfusion in various organs, contributing to end-organ dysfunction [364, 365]
Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made